Essential tremor (ET) is one of the most prevalent neurological diseases. Although the most recognizable clinical feature of ET is tremor, there is emerging evidence that non-motor features (esp. cognitive dysfunction) may be present. A growing number of studies are showing that ET patients have poorer cognitive performance than age-matched controls, yet the cognitive profile among ET patients with cognitive problems has yet to be fully characterized. In some ET patients, the cognitive problems are quite severe. Recent epidemiological studies have demonstrated that ET patients are more likely to have mild cognitive impairment (MCI) than age-matched controls, and an increased risk of dementia (relative risk = 1.64 - 1.89). While ET appears to be a risk factor for the development of cognitive impairment, the cause of cognitive impairment in ET is not currently known. There is early evidence that ET may be associated with an increased risk of developing disorders characterized by tau pathology. The overall goal of the proposed research is to determine the clinical and pathological characteristics of cognitive impairment associated with ET. To accomplish this goal, we plan to perform neuropsychological examinations during life and post-morbid neuropathological examinations on participants in the Essential Tremor Centralized Brain Repository (ETCBR), a well-characterized sample of 250 elderly ET cases who have all already agreed to brain donation (R01NS042859, E. Louis). While their tremor has been well-characterized, neuropsychological testing has been limited to a gross global cognitive evaluation. A central hypothesis for the proposed research is that the majority of ET patients with MCI and dementia will have disorders characterized by tau pathology (Alzheimer's disease or progressive supranuclear palsy). Our 5-year research proposal has two specific aims:
Aim 1 : Characterize the cognitive profile and assign diagnoses of normal cognition, MCI, or dementia in 250 ET patients at baseline and every 18 months.
Aim 2 : Characterize the neuropathological features of 100 brains of patients with ET harvested in Years 1 - 5, including >70 with cognitive impairment.
This aim will include neuropathological and biochemical studies to characterize the molecular signature of the tau protein. The study will test several hypothesized clinical and clinical-pathological relationships (Hypotheses 1A-C, 2A-C). We expect that the proposed research will elucidate the processes of dementia in ET and, in due course, shape the counseling and treatment of ET patients with cognitive symptoms. We anticipate that these will be the gold standard data for the study and characterization of cognitive impairment in ET for years to come, and a tissue resource for future investigators.

Public Health Relevance

Essential tremor (ET), among the most common neurological illnesses, has traditionally been regarded as a purely motor disorder, but there is a growing body of evidence that cognitive dysfunction is also present and, of additional import, that ET itself seems to be a risk factor for the development of dementia. This is an emerging and largely unexplored arena, and the goal of the proposed research is to lead the effort in determining the clinical and pathological characteristics of cognitive impairment associated with ET. We expect that the proposed research will elucidate the origins of and processes of cognitive impairment in ET and, in due course, have an effect on prognostic counseling and treatment of ET patients with emerging cognitive features.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS086736-05
Application #
9483796
Study Section
Adult Psychopathology and Disorders of Aging Study Section (APDA)
Program Officer
Lungu, Codrin Ion
Project Start
2015-07-01
Project End
2019-05-31
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
5
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Yale University
Department
Neurology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
Trujillo Diaz, Daniel; Hernandez, Nora C; Cortes, Etty P et al. (2018) Banking brains: a pre-mortem ""how to"" guide to successful donation. Cell Tissue Bank 19:473-488
Jansen, Willemijn J; Wilson, Robert S; Visser, Pieter Jelle et al. (2018) Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging 61:138-145
Huey, Edward D; Cosentino, Stephanie; Chapman, Silvia et al. (2018) Self-report depressive symptoms are dissociated from tremor severity in essential tremor. Parkinsonism Relat Disord 50:87-93
Zubair, Adeel; Cersonsky, Tess E K; Kellner, Sarah et al. (2018) What Predicts Mortality in Essential Tremor? A Prospective, Longitudinal Study of Elders. Front Neurol 9:1077
Benito-León, Julián; Mato-Abad, Virginia; Louis, Elan D et al. (2017) White matter microstructural changes are related to cognitive dysfunction in essential tremor. Sci Rep 7:2978
Azar, Martina; Bertrand, Elodie; Louis, Elan D et al. (2017) Awareness of cognitive impairment in individuals with essential tremor. J Neurol Sci 377:155-160
Monin, Joan K; Gutierrez, Jesús; Kellner, Sarah et al. (2017) Psychological Suffering in Essential Tremor: A Study of Patients and Those Who Are Close to Them. Tremor Other Hyperkinet Mov (N Y) 7:526
Serrano, J Ignacio; Romero, Juan P; Castillo, Ma Dolores Del et al. (2017) A data mining approach using cortical thickness for diagnosis and characterization of essential tremor. Sci Rep 7:2190
Sánchez-Ferro, Á; Benito-León, J; Louis, E D et al. (2017) Cognition in non-demented Parkinson's disease vs essential tremor: A population-based study. Acta Neurol Scand 136:393-400
Kuo, Sheng-Han; Wang, Jie; Tate, William J et al. (2017) Cerebellar Pathology in Early Onset and Late Onset Essential Tremor. Cerebellum 16:473-482

Showing the most recent 10 out of 58 publications